
TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13961
DO  - doi:10.1111/all.13961
SP  - 376
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts 416–623
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.23302
DO  - doi:10.1002/hep.23302
SP  - 502A
EP  - 599A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 10
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.13033
DO  - doi:10.1111/jdi.13033
SP  - 24
EP  - 44
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 281
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.12919
DO  - doi:10.1111/febs.12919
SP  - 65
EP  - 784
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
JA  - Pediatric Diabetes
VL  - 15
IS  - s19
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12194_2
DO  - doi:10.1111/pedi.12194_2
SP  - 49
EP  - 137
PY  - 2014
ER  - 

TY  - JOUR
AU  - Chou, Che-Yi
AU  - Chang, Chiz-Tzung
AU  - Chen, Chao-Jung
C7  - e8580
C8  - RCM-19-0172.R1
TI  - Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry
JO  - Rapid Communications in Mass Spectrometry
JA  - Rapid Commun Mass Spectrom
VL  - n/a
IS  - n/a
SN  - 0951-4198
UR  - https://doi.org/10.1002/rcm.8580
DO  - doi:10.1002/rcm.8580
SP  - e8580
AB  - Rationale Chronic pancreatitis (CP) is a pancreatic disease with poor prognosis and pancreatic cancer (PC) is one of the most lethal types of cancer that is symptomless in the early stage. Because the clinical and image findings of CP can overlap that of pancreatic cancer (PC) which leads to confusion in the diagnosis and treatment of PC, discovery/verification/validation of more accurate protein biomarkers to diagnose CP and PC is in urgent need. Methods The PubMed, Web of Science, and Google Scholar were searched using the keywords: ?biomarker?, ?marker?, ?chronic pancreatitis?, ?pancreatic cancer? or ?proteomics? for highly related researches. We focused on the articles published after the year 2005 in this review. Results We introduce the background to CP and PC and summarize the diagnosis of CP and PC, analytically validated protein biomarkers, and proteomic approaches for discovery/verification/validation. The potential use of mass spectrometry (MS) in clinical diagnosis is also discussed. Conclusions Continuously improving sensitivity of MS can provide deeper proteome for new marker discovery and high reliability for protein marker verification, validation, and clinical diagnosis. The analytically validated protein markers could be considered as targeted protein biomarkers for developing a MS platform in the clinical validation process or clinical diagnosis of CP and PC.
ER  - 

TY  - JOUR
TI  - Abstracts Oral
JO  - American Journal of Transplantation
VL  - 9
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2009.02658.x
DO  - doi:10.1111/j.1600-6143.2009.02658.x
SP  - 189
EP  - 383
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Presentations and Posters
JO  - Tissue Antigens
JA  - Tissue Antigens
VL  - 85
IS  - 5
SN  - 0001-2815
UR  - https://doi.org/10.1111/tan.12557
DO  - doi:10.1111/tan.12557
SP  - 301
EP  - 431
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 17
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14306
DO  - doi:10.1111/ajt.14306
SP  - 411
EP  - 815
PY  - 2017
ER  - 

TY  - JOUR
TI  - 2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des congrès de Montréal in Montréal, Quebéc, Canada September 28 – October 1, 2018
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 33
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3621
DO  - doi:10.1002/jbmr.3621
SP  - S1
EP  - S464
PY  - 2018
ER  - 

TY  - JOUR
TI  - SIOP 2013 Scientific Programme + Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 60
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24719
DO  - doi:10.1002/pbc.24719
SP  - S1
EP  - S264
PY  - 2013
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14917
DO  - doi:10.1111/ajt.14917
SP  - 245
EP  - 478
PY  - 2018
ER  - 

TY  - JOUR
TI  - Posters on Display
JO  - Pediatric Diabetes
JA  - Pediatr Diabetes
VL  - 18
IS  - S25
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12588
DO  - doi:10.1111/pedi.12588
SP  - 138
EP  - 177
PY  - 2017
ER  - 

TY  - JOUR
AU  - Savage, William J.
AU  - Everett, Allen D.
TI  - Biomarkers in pediatrics: Children as biomarker orphans
JO  - PROTEOMICS – Clinical Applications
JA  - Prot. Clin. Appl.
VL  - 4
IS  - 12
SN  - 1862-8346
UR  - https://doi.org/10.1002/prca.201000062
DO  - doi:10.1002/prca.201000062
SP  - 915
EP  - 921
KW  - Biomarker
KW  - Pediatrics
PY  - 2010
AB  - Abstract Biomarkers have enormous potential to improve patient care by establishing tests of diagnosis, prognosis, and treatment effects. Successfully translating a biomarker from discovery to clinical application demands high-quality discovery research and high-quality clinical studies for biomarker validation; however, there are additional challenges that face biomarker research in pediatrics. There are also additional characteristics of pediatric medicine that make biomarker research especially needed. This review focuses on the fundamentals of biomarkers, the additional considerations needed for applying biomarker research to children, and recommendations for advancing pediatric biomarker research.
ER  - 

TY  - JOUR
TI  - E-Poster
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13512
DO  - doi:10.1111/tri.13512
SP  - 320
EP  - 399
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Neurogastroenterology & Motility
VL  - 23
IS  - s1
SN  - 1350-1925
UR  - https://doi.org/10.1111/j.1365-2982.2011.01758.x
DO  - doi:10.1111/j.1365-2982.2011.01758.x
SP  - 14
EP  - 51
PY  - 2011
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)
JO  - Hepatology
JA  - Hepatology
VL  - 62
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28228
DO  - doi:10.1002/hep.28228
SP  - 714A
EP  - 807A
PY  - 2015
ER  - 

TY  - JOUR
TI  - Moderated Poster
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 25
IS  - S1
SN  - 0919-8172
UR  - https://doi.org/10.1111/iju.13751
DO  - doi:10.1111/iju.13751
SP  - 245
EP  - 375
PY  - 2018
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Nephrology
VL  - 15
IS  - s3
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2010.01336.x
DO  - doi:10.1111/j.1440-1797.2010.01336.x
SP  - 33
EP  - 61
PY  - 2010
ER  - 
